AIMS Our primary aim was to determine the rate of overseas travel in immunocompromised individuals attending appropriate clinics at an Australian tertiary care hospital. We also aimed to characterise health-seeking behaviour prior to travel and investigated sources of pre-travel advice, compared travel patterns and activities between three specific immunosuppressed groups, and examined pre-immu...

Ankylosing spondylitis (AS) is a chronic inflammatory disease of unknown pathogenesis. Nonsteroidal antiinflammatory and biologic drugs are used in its treatment. A 38 year old male patient diagnosed with AS was admitted to the rheumatology outpatient clinic due swelling both upper eyelids around eyes recurring for 1 month. He at 5th month etanercept With current clinic, etanercept-induced angi...

vasculitides are a heterogeneous group of more than 20 diseases defined by inflammation and destruction of blood vessels. we aimed to study the demographic characteristics of the primary vasculitides in the north east of iran. we retrospectively studied the medical records of patients diagnosed with any kind of vasculitis at the clinic and department of rheumatology of the imam reza hospital, m...

referrals which they dealt with. At the end of the 15 month period, this was analysed with regard to demographic data, specialties generating the referral, final rheumatologic diagnosis, response time and the outcome. They were supported by 7.6 WTE consultants who run a separate rheumatology on call rota and a weekly rapid access clinic. Results: A total of 135 patients were seen by the registr...

Pediatric rheumatology is still considered a mysterious branch of pediatric medicine, especially among developing countries. Long-term consequences usually follow delayed diagnosis, referral, and management of rheumatic disorders. We aim to describe the clinical spectrum and the frequency of pediatric rheumatic diseases (PRDs) in AL-Mukalla hospital in Hadhramout province/Yemen. A case record r...

INTRODUCTION The presence of anti-topoisomerase I (topo I) antibodies is a classic scleroderma (SSc) marker presumably associated with a unique clinical subset. Here the clinical association of anti-topo I was reevaluated in unselected patients seen in a rheumatology clinic setting. METHODS Sera from the initial visit in a cohort of unselected rheumatology clinic patients (n = 1,966, includin...